Cashin, Kieran
Gray, Lachlan R.
Harvey, Katherine L.
Perez-Bercoff, Danielle
Lee, Guinevere Q.
Sterjovski, Jasminka
Roche, Michael
Demarest, James F.
Drummond, Fraser
Harrigan, P. Richard
Churchill, Melissa J.
Gorry, Paul R.
Article History
Received: 20 October 2014
Accepted: 23 January 2015
First Online: 25 February 2015
Competing interests
: JFD and FD are employees of ViiV Healthcare. PRG is a former member of the ViiV Australia scientific advisory board and has received honoraria. KC and PRG have received honoraria from ViiV Healthcare Australia for conference travel. PRH is supported by CIHR/GSK Research Chair in Clinical Virology and has consulted and/or received grant funding from a variety pharmaceutical diagnostic companies and has received grants from, served as an ad hoc advisor to, or spoke at various events sponsored by: Pfizer, Glaxo-Smith Kline, Abbott, Merck, Selah, Tobira, Virco and Quest Diagnostics. None of the other authors have any competing interests to declare.